BR112023025213A2 - Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante - Google Patents

Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante

Info

Publication number
BR112023025213A2
BR112023025213A2 BR112023025213A BR112023025213A BR112023025213A2 BR 112023025213 A2 BR112023025213 A2 BR 112023025213A2 BR 112023025213 A BR112023025213 A BR 112023025213A BR 112023025213 A BR112023025213 A BR 112023025213A BR 112023025213 A2 BR112023025213 A2 BR 112023025213A2
Authority
BR
Brazil
Prior art keywords
analgesic
antioxidant
combination
food
ketogenic compound
Prior art date
Application number
BR112023025213A
Other languages
English (en)
Inventor
Elena Gross
Original Assignee
Ketoswiss Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ketoswiss Ag filed Critical Ketoswiss Ag
Publication of BR112023025213A2 publication Critical patent/BR112023025213A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante. a presente invenção está no campo de produtos farmacêuticos, produtos alimentícios ou suplementos funcionais, e alimentos medicinais ou alimento para fins médicos especiais (fsmp). em particular, a presente invenção se refere a uma combinação de (i) um corpo cetônico e/ou um composto cetogênico e (ii) um analgésico e/ou um antioxidante, para o uso no tratamento e/ou prevenção de dor, tal como dor de cabeça, enxaqueca e/ou sintomas de enxaqueca em um sujeito. além disso, a invenção se refere a uma composição compreendendo (i) um corpo cetônico e/ou um composto cetogênico e (ii) um analgésico e/ou um antioxidante, tal como uma composição farmacêutica, um produto alimentício, um suplemento alimentar, um auxiliar nutricional, um alimento medicinal ou alimento para fins médicos especiais (fsmp), e usos dos mesmos.
BR112023025213A 2021-07-17 2022-07-17 Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante BR112023025213A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21186274 2021-07-17
PCT/EP2022/069972 WO2023001724A1 (en) 2021-07-17 2022-07-17 Combination of a ketone body or ketogenic compound with an analgesic or antioxidant

Publications (1)

Publication Number Publication Date
BR112023025213A2 true BR112023025213A2 (pt) 2024-02-27

Family

ID=76971654

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023025213A BR112023025213A2 (pt) 2021-07-17 2022-07-17 Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante

Country Status (7)

Country Link
EP (1) EP4373483A1 (pt)
KR (1) KR20240037239A (pt)
CN (1) CN117677383A (pt)
AU (1) AU2022315496A1 (pt)
BR (1) BR112023025213A2 (pt)
CA (1) CA3219283A1 (pt)
WO (1) WO2023001724A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015216A1 (en) 1998-09-15 2000-03-23 Btg International Limited Therapeutic compositions (ii)
EP2240017B1 (en) * 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
ES2655367T3 (es) 2008-08-21 2018-02-19 Oxford University Innovation Limited Bebida que comprende éster de hidroxibutirato y uso médico de la misma
GB201206192D0 (en) 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
EP3042571A1 (en) 2014-12-15 2016-07-13 Anabio Technologies Limited A solution of denatured pea protein, and uses thereof to form microbeads
US20180200220A1 (en) * 2015-07-10 2018-07-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using ketogenic medium chain triglycerides, ketone esters, and other ketogenic sources
FI3558280T3 (fi) 2016-12-21 2023-07-13 Univ Kinderspital Beider Basel Migreenin ennaltaehkäisy ja hoito
US10500182B2 (en) 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
US10512615B1 (en) * 2018-08-27 2019-12-24 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US20220257546A1 (en) 2019-05-10 2022-08-18 Ketoswiss Ag Ketone bodies enclosed in microbeads

Also Published As

Publication number Publication date
KR20240037239A (ko) 2024-03-21
AU2022315496A1 (en) 2023-12-07
EP4373483A1 (en) 2024-05-29
CA3219283A1 (en) 2023-01-26
WO2023001724A1 (en) 2023-01-26
CN117677383A (zh) 2024-03-08

Similar Documents

Publication Publication Date Title
Gao et al. Biomedical applications of Aloe vera
Mohan et al. Spirulina, the nature’s wonder: A review
Aruoma et al. Functional benefits of ergothioneine and fruit-and vegetable-derived nutraceuticals: overview of the supplemental issue contents
BR112013001717A2 (pt) tratamento de síndrome de imunodeficiência adquirida (aids) com propriedades antivirais de aloe vera
BRPI0410267A (pt) composições contendo enzimas, produtos alimentares dietéticos e medicamentos produzidos das mesmas e sua utilização para fins medicinais
MX2022010964A (es) Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada.
US8197871B2 (en) Composition for headache treatment
Sumera et al. The micronutrient combination with immune-enhancing effects
BR112023025213A2 (pt) Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante
Smithson et al. Nutritional modulators of pain in the aging population
US20220323535A1 (en) Health supplement
JP2008156306A (ja) ボイセンベリー果実由来の材料及びその材料を用いたサプリメント、薬剤又は食品
US20130316017A1 (en) Oral Composition for the Treatment of Acne
MX2022010948A (es) COMPOSICIÓN O EXTRACTO DE AVENA QUE COMPRENDE AVENANTRAMIDA Y ß-GLUCANO.
JP6159382B2 (ja) 経口紫外線抵抗性向上剤
ES2581180B1 (es) Uso de aloe oral para la mejora capilar
PL435961A1 (pl) Kompozycja zawierająca kwas rozmarynowy oraz zastosowanie kwasu rozmarynowego
Sathiyaraj et al. In vitro evaluation of antibacterial, antioxidant, and anticancer properties of panchagavya
PL425235A1 (pl) Zastosowanie izoksantohumolu
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
Hasan Natural Antioxidants in Medicinal Plants: For Better or for Worse?
Agrawal et al. Translational Research and Clinical Advancements with Nutraceutical Supplements
Arain et al. Effects of aloe vera in local massage oils in alternative medicine for the treatment of joint pains: a double blind study
MX2022010949A (es) Composiciones de avenantramida con solubilidad mejorada que comprenden 4-hidroxifenona.
Chianetta et al. Nutraceuticals and Cardiovascular Disease